069620.KS Daewoong pharmaceutical Co.,Ltd
KSCHealthcareAs of 2026-08-09 03:19
Why 069620.KS matters now
Daewoong pharmaceutical Co.,Ltd (069620.KS) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩129,000.00 with +0.78% on the session and ₩1.49T in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 8.16, gross margin 36.9%, and operating margin 11.7%.
Valuation
P/E (TTM)
8.16
PEG
—
P/B
1.46
P/S
0.91
EV/EBITDA
9.62
DCF Value
—
FCF Yield
-7.4%
Div Yield
0.5%
Margins & Returns
Gross Margin
36.9%
Operating Margin
11.7%
Net Margin
11.1%
ROE
19.4%
ROA
7.4%
ROIC
8.9%
Listing Info
Market
Korea
Exchange
KSC
Currency
KRW
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
KR
Established in 1945 and headquartered in Seoul, South Korea, Daewoong Pharmaceutical Co., Ltd. is a global entity dedicated to the research, production, and international distribution of a diverse range of pharmaceutical products. Its extensive portfolio provides therapeutic solutions across numerous health disciplines, including treatments for central nervous system disorders, endocrine conditions, musculoskeletal ailments, nephrological issues, oncology, cardiovascular diseases, gastrointestinal complaints, and metabolic dysfunctions. The company further offers products addressing viral infections, pain relief, antacids, digestive problems, wound care, and nutritional supplements such as iron and multivitamins. Complementing its pharmaceutical offerings, Daewoong also supplies medical devices, notably COVID-19 PCR and IgG/IgM RDT diagnostic kits, along with viral transport media.